France restores old thyroid drug after complaints over new one

September 15, 2017
The side effects of the new version of Levothyrox that went on sale in March are said to include cramps, headaches, dizziness and hair loss

An old version of a thyroid medication will be reintroduced in France after thousands of the country's three million users complained of serious side effects from a new formula, the government said Friday.

The side effects of the new of Levothyrox that went on sale in March are said to include cramps, headaches, dizziness and .

The government of President Emmanuel Macron, which has been accused of "shameful indifference" over the scandal, said the old version of the would be reintroduced in two weeks.

The German producer of the drug, Merck Serono, said the new version of the treatment was set to be approved in other European countries.

The French drug watchdog Agence Francaise du Medicament had asked Merck to develop the new formula, which is stabler than the old version, in 2012.

Health Minister Agnes Buzyn told France Inter radio that "alternatives, other brands, other drugs" would be available in a month.

"Gradually... patients will be able to choose the drug that suits them the best," she said.

Only one alternative is currently available in France, L-Thyroxine.

As of Monday, more than 9,000 patients had reported undesirable side effects.

Chantal L'Hoir, the head of a support group, told AFP her association was receiving an average of 1,000 complaints a day.

Levothyrox is used to treat underactive thyroids or following surgery for cancer of the organ, which regulates the body's metabolism.

France is the world's leading consumer of Levothyrox and the first country where the new version was introduced.

France was last hit by a major drug scandal in 2010, when it was revealed that the off-label use of a diabetes drug called Mediator for weight loss could cause fatal heart problems.

The legal fallout from that episode is ongoing.

Explore further: Africa gets generic version of most effective HIV drug

Related Stories

Africa gets generic version of most effective HIV drug

June 28, 2017
The generic version of the most advanced drug against HIV has been introduced in Kenya, a first in Africa where more than 25 million have the disease, the NGO Unitaid said Wednesday.

Epilepsy drug behind up to 4,100 'severe birth defects' in France

April 20, 2017
The epilepsy medication valproate is responsible for "severe malformations" in 2,150 to 4,100 children in France since the drug was first marketed in the country in 1967, according to a preliminary study by French health ...

Merck wins approval for long-delayed surgery revival drug

December 15, 2015
Federal health authorities have approved a new drug that helps patients recover from the numbing effects of certain surgical drugs.

France to call for lower drug prices at G7

March 22, 2016
France will announce a campaign to lower the price of new medicines, hoping world powers at the upcoming G7 meeting will put pressure on the pharmaceutical industry, its health minister said Tuesday.

Recommended for you

Discovery opens door for synthetic opioids with less addictive qualities

June 1, 2018
Making opioids from sugar instead of from field grown opium poppies has the potential to solve many of the problems associated with manufacturing strong pain killers.

US doctors prescribing fewer opioid painkillers: report

May 31, 2018
US doctors reduced the number of prescriptions for opioid painkillers last year, continuing a five-year trend, in an effort to reverse a deadly drug abuse epidemic, a report released Thursday said.

Researchers publish study on new therapy to treat opioid use disorder

May 22, 2018
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

Could nonprofit drug companies cut sky-high prices?

May 17, 2018
(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now a group of U.S. hospitals thinks it has a solution: a nonprofit drug maker.

Fewer antibiotics for kids, but more ADHD drugs

May 15, 2018
(HealthDay)—American kids are taking fewer prescription medications these days—but certain drugs are being prescribed more than ever, a new government study finds.

Opioid makers' perks to docs tied to more prescriptions

May 14, 2018
Doctors who accept perks from companies that make opioid painkillers are more likely to prescribe the drugs for their patients, new research suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.